FABP3P2

Across TCGA pan-cancer cohorts, FABP3P2 RNA is linked to patient survival in 15 of 34 cancer types, making it the most broadly survival-associated FABP3P2 data layer.

The strongest signal is observed in lymphoid neoplasm diffuse large b-cell lymphoma (DLBC), where higher FABP3P2 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated FABP3P2 expression acts as an unfavorable survival marker, although some lineages such as ACC and COAD show a favorable association.

DLBC, SKCM, and THCA are the cancer types where FABP3P2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
DLBC	OS	Tertile	II,III,IV	0.172	0.949	<.001	72	view →
SKCM	OS	Tertile	All	0.423	0.788	<.001	45	view →
THCA	DFS	Tertile	II,III,IV	0.145	0.842	<.001	45	view →
LGG	DFS	Tertile	All	0.207	0.413	.002	39	view →
STAD	OS	Tertile	All	0.232	0.576	.002	36	view →
TGCT	DFS	Tertile	II,III,IV	0.015	0.919	<.001	36	view →
ESCA	OS	Tertile	IV	0.095	0.512	.008	36	view →
ACC	OS	Tertile	III,IV	1.000	0.647	.025	36	view →
READ	OS	Tertile	All	0.263	0.715	.009	36	view →
LIHC	DFS	Tertile	All	0.069	0.555	<.001	36	view →
COAD	DFS	Tertile	III,IV	1.000	0.644	.009	30	view →
MESO	OS	Tertile	All	0.279	0.554	.013	27	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 15 lineages.

FABP3P2–DLBC (OS)

Open the DLBC breakdown →